newsfilter
← Latest News
Business Wire·

Model N Responds to Mounting Regulatory Pharma Pressures with Innovations that Ensure Compliance and Optimize Revenue

340B, Inflation Reduction Act, and global pricing innovations help leading life sciences companies manage regulatory, compliance, and discounting challenges Model N (NYSE:MODN), the leader in revenue optimization and